Compare Stocks

Date Range: 

 Canopy GrowthTilraySTADA Arzneimittel AktiengesellschaftCronos GroupUSANA Health Sciences
SymbolNASDAQ:CGCNASDAQ:TLRYOTCMKTS:STDAFNASDAQ:CRONNYSE:USNA
Price Information
Current Price$22.98$16.91$110.42$8.35$100.71
52 Week RangeHoldHoldN/AHoldBuy
MarketRank™
Overall Score1.21.20.40.81.7
Analysis Score4.13.20.00.83.5
Community Score1.32.32.02.32.2
Dividend Score0.00.00.00.00.0
Ownership Score0.00.00.00.00.8
Earnings & Valuation Score0.60.60.00.61.9
Analyst Ratings
Consensus RecommendationHoldHoldN/AHoldBuy
Consensus Price Target$32.90$20.28N/A$8.80$126.00
% Upside from Price Target43.17% upside19.90% upsideN/A5.39% upside25.11% upside
Trade Information
Market Cap$8.80 billion$7.57 billion$6.87 billion$3.10 billion$2.08 billion
Beta2.112.650.521.790.92
Average Volume5,346,53934,360,805N/A4,766,761107,609
Sales & Book Value
Annual Revenue$414.03 million$210.48 million$2.92 billion$46.72 million$1.13 billion
Price / Sales21.2535.942.3566.421.83
CashflowN/AN/A$11.26 per shareN/A$6.74 per share
Price / CashN/AN/A9.81N/A14.94
Book Value$6.90 per share$1.21 per share$21.48 per share$4.74 per share$20.99 per share
Price / Book3.3313.985.141.764.80
Profitability
Net Income$-1,322,470,000.00$-271,070,000.00$339.02 million$-73,140,000.00$124.66 million
EPS($2.16)($0.83)N/A($0.38)$5.86
Trailing P/E RatioN/AN/A0.00N/A16.56
Forward P/E RatioN/AN/AN/A15.71
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-311.30%-336.84%N/A-610.02%10.95%
Return on Equity (ROE)-18.67%-136.31%N/A-11.39%32.54%
Return on Assets (ROA)-12.58%-43.56%N/A-10.00%22.24%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.45%0.48%N/A0.01%N/A
Current Ratio9.98%2.01%N/A4.36%2.46%
Quick Ratio8.69%1.67%N/A4.21%1.89%
Ownership Information
Institutional Ownership Percentage12.73%7.06%N/A13.09%55.33%
Insider Ownership Percentage0.26%16.75%N/A5.52%0.21%
Miscellaneous
Employees3,2591,03011,1006311,943
Shares Outstanding382.93 million447.37 million62.22 million371.66 million20.62 million
Next Earnings Date8/9/2021 (Estimated)8/9/2021 (Estimated)N/A8/5/2021 (Estimated)7/20/2021 (Estimated)
OptionableOptionableOptionableNot OptionableOptionableOptionable
SourceHeadline
USANA CEO Elected as Chairman of the Board of Direct Selling AssociationUSANA CEO Elected as Chairman of the Board of Direct Selling Association
finance.yahoo.com - June 17 at 1:54 PM
Introducing USANA Health Sciences (NYSE:USNA), A Stock That Climbed 85% In The Last Five YearsIntroducing USANA Health Sciences (NYSE:USNA), A Stock That Climbed 85% In The Last Five Years
finance.yahoo.com - June 11 at 9:02 PM
USANA director of human resources awarded for outstanding achievement her in fieldUSANA director of human resources awarded for outstanding achievement her in field
finance.yahoo.com - June 7 at 12:47 PM
USANA Health Sciences (NYSE:USNA) Hits New 52-Week High at $107.39USANA Health Sciences (NYSE:USNA) Hits New 52-Week High at $107.39
americanbankingnews.com - June 1 at 11:58 AM
Is Now The Time To Look At Buying USANA Health Sciences, Inc. (NYSE:USNA)?Is Now The Time To Look At Buying USANA Health Sciences, Inc. (NYSE:USNA)?
nasdaq.com - May 25 at 2:29 PM
USANA and Beijing University of Chinese Medicine sign research collaboration agreementUSANA and Beijing University of Chinese Medicine sign research collaboration agreement
prnewswire.com - May 21 at 11:02 AM
At Mental Health Months Halfway Mark, Bestselling Author/CEO Offers 6 Steps for Pandemic ReliefAt Mental Health Month's Halfway Mark, Bestselling Author/CEO Offers 6 Steps for Pandemic Relief
finance.yahoo.com - May 18 at 1:00 PM
Winners in 2021 Asia-Pacific Stevie Awards AnnouncedWinners in 2021 Asia-Pacific Stevie Awards Announced
markets.businessinsider.com - May 13 at 9:55 PM
USANA Health Sciences, Inc.s (NYSE:USNA) Stock Is Going Strong: Is the Market Following Fundamentals?USANA Health Sciences, Inc.'s (NYSE:USNA) Stock Is Going Strong: Is the Market Following Fundamentals?
finance.yahoo.com - May 12 at 1:34 PM
USANA Health Sciences, Inc. (USNA) CEO Kevin Guest on Q1 2021 Results - Earnings Call TranscriptUSANA Health Sciences, Inc. (USNA) CEO Kevin Guest on Q1 2021 Results - Earnings Call Transcript
seekingalpha.com - April 30 at 2:41 AM
USANA Health Sciences, Inc. Just Missed Earnings - But Analysts Have Updated Their ModelsUSANA Health Sciences, Inc. Just Missed Earnings - But Analysts Have Updated Their Models
nasdaq.com - April 29 at 11:39 AM
USANA Health Sciences Inc (USNA) Q1 2021 Earnings Call TranscriptUSANA Health Sciences Inc (USNA) Q1 2021 Earnings Call Transcript
fool.com - April 28 at 3:37 PM
USANA Health Sciences Raises FY OutlookUSANA Health Sciences Raises FY Outlook
nasdaq.com - April 28 at 1:25 AM
Recap: Usana Health Sciences Q1 EarningsRecap: Usana Health Sciences Q1 Earnings
benzinga.com - April 27 at 8:24 PM
USANA Health: Q1 Earnings SnapshotUSANA Health: Q1 Earnings Snapshot
apnews.com - April 27 at 8:24 PM
USANA Health Sciences Q1 Earnings AdvanceUSANA Health Sciences Q1 Earnings Advance
nasdaq.com - April 27 at 8:24 PM
USANA Health Sciences (USNA) Q1 Earnings Lag EstimatesUSANA Health Sciences (USNA) Q1 Earnings Lag Estimates
finance.yahoo.com - April 27 at 8:24 PM
Direct Selling News honors USANA and its CEO with three major awardsDirect Selling News honors USANA and its CEO with three major awards
finance.yahoo.com - April 26 at 5:33 PM
USANAs Environmental, Social, and Governance initiative aims to make a positive, lasting impact for the earth and the USANA FamilyUSANA's Environmental, Social, and Governance initiative aims to make a positive, lasting impact for the earth and the USANA Family
finance.yahoo.com - April 22 at 3:38 PM
Seek Mentor in Pandemic, Global Author/CEO SaysSeek Mentor in Pandemic, Global Author/CEO Says
finance.yahoo.com - April 13 at 12:13 PM
PNP: Police can’t arrest quarantine violatorsPNP: Police can’t arrest quarantine violators
newsinfo.inquirer.net - April 11 at 7:23 AM
Do USANA Health Sciencess (NYSE:USNA) Earnings Warrant Your Attention?Do USANA Health Sciences's (NYSE:USNA) Earnings Warrant Your Attention?
finance.yahoo.com - April 9 at 5:31 PM
USANA Dives Into Partnership With USA SwimmingUSANA Dives Into Partnership With USA Swimming
finance.yahoo.com - April 7 at 12:32 PM
Usana Health Sciences Stock Appears To Be Fairly ValuedUsana Health Sciences Stock Appears To Be Fairly Valued
finance.yahoo.com - March 28 at 5:53 PM
USNA vs. ZTS: Which Stock Should Value Investors Buy Now?USNA vs. ZTS: Which Stock Should Value Investors Buy Now?
finance.yahoo.com - March 17 at 1:38 PM
DateCompanyBrokerageAction
6/3/2021Canopy GrowthDesjardinsLower Price Target
6/2/2021Canopy GrowthCIBCLower Price Target
6/2/2021Canopy GrowthEight CapitalUpgrade
6/1/2021Canopy GrowthCanaccord GenuityUpgrade
6/1/2021Canopy GrowthAlliance Global PartnersReiterated Rating
5/25/2021Canopy GrowthMKM PartnersUpgrade
4/28/2021Canopy GrowthBank of AmericaInitiated Coverage
4/9/2021Canopy GrowthCantor FitzgeraldLower Price Target
2/24/2021Canopy GrowthJefferies Financial GroupDowngrade
2/10/2021Canopy GrowthCormarkDowngrade
2/10/2021Canopy GrowthBMO Capital MarketsReiterated Rating
2/10/2021Canopy GrowthBenchmarkDowngrade
2/5/2021Canopy GrowthPiper SandlerDowngrade
2/4/2021Canopy GrowthStifel NicolausReiterated Rating
5/11/2021TilrayCowenInitiated Coverage
2/18/2021TilrayRoth CapitalBoost Price Target
8/11/2020TilrayNorthland SecuritiesReiterated Rating
8/10/2020TilrayOppenheimerReiterated Rating
6/15/2021Cronos GroupRaymond JamesSet Price Target
5/11/2020Cronos GroupPi FinancialReiterated Rating
5/12/2020USANA Health SciencesTigress FinancialReiterated Rating
7/24/2019USANA Health SciencesPivotal ResearchReiterated Rating
7/3/2019USANA Health SciencesSidotiDowngrade
(Data available from 6/20/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.